Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity

BACKGROUND: MET-driven acquired resistance is emerging with unanticipated frequency in patients relapsing upon molecular therapy treatments. However, the determination of MET amplification remains challenging using both standard and next-generation sequencing-based methodologies. Liquid biopsy is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bersani, Francesca, Picca, Francesca, Morena, Deborah, Righi, Luisella, Napoli, Francesca, Russo, Mariangela, Oddo, Daniele, Rospo, Giuseppe, Negrino, Carola, Castella, Barbara, Volante, Marco, Listì, Angela, Zambelli, Vanessa, Benso, Federica, Tabbò, Fabrizio, Bironzo, Paolo, Monteleone, Emanuele, Poli, Valeria, Pietrantonio, Filippo, Di Nicolantonio, Federica, Bardelli, Alberto, Ponzetto, Carola, Novello, Silvia, Scagliotti, Giorgio V., Taulli, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176894/
https://www.ncbi.nlm.nih.gov/pubmed/37170152
http://dx.doi.org/10.1186/s13046-023-02690-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176894/
https://www.ncbi.nlm.nih.gov/pubmed/37170152
http://dx.doi.org/10.1186/s13046-023-02690-5

Ejemplares similares